Viewing Study NCT07085767

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 12:39 AM

Ignite Modification Date: 2026-02-24 @ 10:06 AM

Study NCT ID: NCT07085767

Status: RECRUITING

Last Update Posted: 2025-12-02

First Post: 2025-07-08

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Sponsor: Olema Pharmaceuticals, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module